ALLMedicine™ Thrombolytic Therapy Center

Jan 15th, 2022 - The clinical symptoms of perforating arteries differ, and responses to intravenous thrombolytic therapy are heterogeneous. Here, we investigated the effect of intravenous thrombolytic therapy and the related factors influencing acute perforating a...

Jan 8th, 2022 - Acute ischemic stroke (AIS) has a significant impact on different aspects of the patient's life resulting in loss of independence and poor Health-related Quality of life (HR-QoL). This study aimed to evaluate the impact of AIS on HR-QoL during the...

Jan 5th, 2022 - Deep vein thrombosis is a major source of morbidity and mortality worldwide. For acute proximal deep vein thrombosis, catheter-directed thrombolytic therapy is an accepted method for vessel recanalization. Thrombolytic therapy is not without risk,...

Dec 30th, 2021 - Perioperative administration of tranexamic acid has been suggested to reduce bleeding and blood transfusion requirements in patients undergoing orthopedic surgery. Despite being sporadic, the potential risk for thrombotic complications cannot be i...

Dec 29th, 2021 - In wake-up stroke patients, magnetic resonance imaging (MRI) is useful to identify patients that would benefit from thrombolytic therapy. Our multidisciplinary stroke team developed and implemented a workflow to rapidly identify patients that are ...

Jan 26th, 2021 - Traumatic hemothorax poses diagnostic and therapeutic challenges both acutely and chronically. A working group of the Eastern Association for the Surgery of Trauma convened to formulate a practice management guideline for traumatic hemothorax. We ...

Aug 26th, 2018 - The risk of stroke is heterogeneous across different groups of patients with atrial fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide recommendations for antithrombotic treatment based on net clinical be...

Mar 22nd, 2018 - Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition).|2018|Horlocker TT,Vandermeuelen E,Kopp SL,Gogarten W,Leffert...

May 29th, 2013 - The last update of the consensus statement on intravenous recombinant tissue plasminogen activator (IV rt-PA) for acute ischemic stroke (AIS) by the Chinese Stroke Therapy Expert Panel was published in 2006. Great progress has been made since then...

Mar 27th, 2013 - Thrombolytic therapy.|2013|Nicolaides A,Hull RD,Fareed J, , ,|therapeutic use,drug therapy,methods,drug therapy,

Dec 15th, 2021 - Acute myocardial infarction (AMI) is one of the leading causes of death all over the world. Even if patients with AMI survive the acute period without death, some ones would inevitably develop into chronic heart failure due to myocardial ischemia ...

Oct 20th, 2021 - Patients presenting to the participating hospitals with a heart attack will be approached to participate in the study. After angioplasty has been performed, the IMR will be measured in the infarct related artery. If the IMR is >32 patients will be...

Aug 20th, 2021 - Cerebral stroke, the first cause of death in China, seriously affects the health and living of people.Its high incidence, disability, mortality and recurrence rate give a heavy burden on the family, society and country. According to TOAST classifi...

Jul 20th, 2021 - In high risk pulmonary embolism , the main aim of therapy is to rapidly recanalize the affected pulmonary arteries with thrombolysis or embolectomy; to decrease right ventricular afterload and reverse right ventricular failure and shock, prevent c...

Feb 9th, 2021 - This is a prospective, international, multicenter outcome cohort study. This study starts at the moment patients visit the outpatient clinic 3 to 6 months after a diagnosis of acute PE as part of routine medical care. If patients consent to study ...

Jan 12th, 2022 - NEW YORK (Reuters Health) - For children with acute provoked venous thromboembolism (VTE), six weeks of anticoagulant therapy is as effective as a three-month course of anticoagulant therapy, results of a new clinical trial suggest. "When treatmen...

Mar 18th, 2021 - Updated March 26, 2021 // Editor's note: This story was updated with comments from Dr Mitchell S. V. Elkind of Columbia University. Among patients with acute ischemic stroke, treatment in a mobile stroke unit (MSU) is associated with better functi...

Oct 30th, 2020 - The American Society of Hematology (ASH) released their updated recommendations on the management of venous thromboembolism (VTE) (deep vein thrombosis [DVT] and pulmonary embolism [PE]) in October 2020.[1] Select recommendations are outlined belo...

Oct 30th, 2020 - The American Society of Hematology (ASH) released their updated recommendations on the management of venous thromboembolism (VTE) (deep vein thrombosis [DVT] and pulmonary embolism [PE]) in October 2020.[1] Select recommendations are outlined belo...

Jun 3rd, 2020 - Shorter times to thrombolytic therapy in acute stroke led to better long-term survival and lower readmission risk, an analysis of Medicare patients showed. One year later, ischemic stroke patients treated with intravenous tissue plasminogen activa...